OR WAIT null SECS
August 01, 2022
The European Commission has approved Rinvoq (upadacitinib) for treatment of active non-radiographic axial spondyloarthritis.
The European Commission has granted marketing authorization to Upstaza (eladocagene exuparvovec) for treatment of aromatic L-amino acid decarboxylase (AADC) deficiency.
July 27, 2022
WuXi STA is opening a new large-scale oligonucleotide and peptide manufacturing facility.
July 26, 2022
Scrutiny of accelerated approvals has generated a range of reform proposals to accelerate the conduct of confirmatory studies.
July 25, 2022
WHO has determined that monkeypox constitutes a public health emergency of international concern.
The agency’s human medicines committee recommended drugs to treat breast cancer, lupus nephritis, type 2 diabetes and more.
A joint statement calling for international collaboration on the creation and use of real-world evidence has been published by the International Coalition of Medicines Regulatory Authorities.
July 20, 2022
Hospira has issued a voluntary nationwide recall for one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), due to the potential presence of visible particulate.
July 19, 2022
TFF Pharmaceuticals is expanding its R&D operations with a new facility in Austin, Texas.
July 18, 2022
Health Canada has authorized Moderna’s COVID-19 vaccine for use in young children aged six months to five years.